Triple
T19992662
| Position | Surface form | Disambiguated ID | Type / Status |
|---|---|---|---|
| Subject | APOE ε3 allele |
E494101
|
entity |
| Predicate | associatedWithAlzheimersDiseaseRiskRelativeToAPOE ε2 |
P133002
|
FINISHED |
| Object | higher risk |
—
|
LITERAL FINISHED |
How this triple was built (2 steps)
Every LLM step that produced this triple, in pipeline order — named-entity classification, the disambiguation choices (the exact options shown, with the pick highlighted), and the generated description. The batch + timestamp of each is in the Provenance table below.
NER
Named-entity recognition
gpt-5-mini
Instruction
Given a phrase, classify it is english named entity (e.g., persons, organizations, works of art) in Latin script, or not (e.g., literals, dates, URLs, verbose phrases). For disambiguation, the statement where the phrase occurs as object is also given. Please return a JSON object with `phrase` (string, the phrase being analyzed) and `is_ne` (boolean, indicating whether the phrase is a Named Entity).
Input
Phrase: higher risk | Statement: [APOE ε3 allele, associatedWithAlzheimersDiseaseRiskRelativeToAPOE ε2, higher risk]
PD
Predicate disambiguation
gpt-5-mini-2025-08-07
Target predicate: associatedWithAlzheimersDiseaseRiskRelativeToAPOE ε2 Context triple: [APOE ε3 allele, associatedWithAlzheimersDiseaseRiskRelativeToAPOE ε2, higher risk]
-
A.
geneticAffinity
Indicates a relationship where entities share a notable degree of genetic similarity or relatedness.
-
B.
associatedWithPhenotype
chosen
Indicates that an entity has a documented connection or correlation with a particular phenotype or observable trait.
-
C.
hasPharmacogenomicAssociation
Indicates that there is a documented relationship between a genetic variant and a drug’s response, efficacy, or toxicity.
-
D.
geneticInfluence
Indicates that one entity affects or contributes to the genetic traits, characteristics, or heredity of another entity.
-
E.
epidemiologicalRisk
Indicates a relationship where one entity poses or is associated with a potential risk of disease occurrence, transmission, or impact to another entity or population from an epidemiological perspective.
- F. None of above.
Provenance (3 batches)
The batch behind each pipeline step, in order, with when it ran. Timestamps are batch-level — stages were processed in waves, so the object chain (NER → NED1 → NEDg → NED2) reads in order, but predicate / elicitation batches can sit in a different wave.
| Step | Stage | Batch ID | Status | When |
|---|---|---|---|---|
| creating | Elicitation | batch_69da626a67648190af9653832a3aeced |
completed | April 11, 2026, 3:02 p.m. |
| NER | Named-entity recognition | batch_69e65fe10ffc81908c94168b0a8ea9c9 |
completed | April 20, 2026, 5:18 p.m. |
| PD | Predicate disambiguation | batch_69e537fd311881908448f2aea8b4812e |
completed | April 19, 2026, 8:15 p.m. |
Created at: April 11, 2026, 3:31 p.m.